Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes.
Jarvis, Joseph N; Bicanic, Tihana; Loyse, Angela; Namarika, Daniel; Jackson, Arthur; Nussbaum, Jesse C; Longley, Nicky; Muzoora, Conrad; Phulusa, Jacob; Taseera, Kabanda; Kanyembe, Creto; Wilson, Douglas; Hosseinipour, Mina C; Brouwer, Annemarie E; Limmathurotsakul, Direk; White, Nicholas; van der Horst, Charles; Wood, Robin; Meintjes, Graeme; Bradley, John; Jaffar, Shabbar; Harrison, Thomas.
Clin Infect Dis
; 58(5): 736-45, 2014 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-24319084
T cell susceptibility to HIV influences outcome of opportunistic infections.
Early versus delayed antiretroviral treatment in HIV-positive people with cryptococcal meningitis.
Interleukin-2 as an adjunct to antiretroviral therapy for HIV-positive adults.
Isoniazid for preventing tuberculosis in HIV-infected children.
Nutritional interventions for reducing morbidity and mortality in people with HIV.
The changing trends and profile of pneumocystosis mortality in the United States, 1999-2014.
Comparing clinical outcomes in HIV-infected and uninfected older men hospitalized with community-acquired pneumonia.
Updating vital status by tracking in the community among patients with epidemic Kaposi sarcoma who are lost to follow-up in sub-Saharan Africa.
A decade of antiretroviral therapy in Uganda: what are the emerging causes of death?
Antiretroviral therapy improves survival among TB-HIV co-infected patients who have CD4+ T-cell count above 350cells/mm<sup>3</sup>.